
Aug 9, 2026 · 9 min
AI demand meets costly infrastructure as earnings loom
Week Ahead: Hims & Hers, CoreWeave, Cava Group
The episode frames three different earnings tests: subscriber momentum and legal risk, AI infrastructure economics, and food-safety fallout.
- 1Hims & Hers faces an earnings test around subscriber growth, its AI-native care app, and an ongoing FTC lawsuit.
- 2CoreWeave must show whether strong AI demand can outweigh expensive data centers and substantial debt.
- 3CAVA Group enters earnings with food-safety headlines and parasite scares clouding its fast-casual growth story.
Don't miss
The CoreWeave discussion crystallizes the episode’s main question: whether AI demand can offset the high costs of infrastructure and debt.
The brief
Bloomberg’s Nathan Hager and Judy Lagrou preview earnings from Hims & Hers, CoreWeave, and CAVA Group, focusing on the specific risks investors will be watching.
Hims & Hers faces questions about subscriber growth and a new AI-native care app while an ongoing FTC lawsuit adds legal uncertainty to its outlook.
CoreWeave’s central tension is straightforward: heavy AI demand could support growth, but data-center costs and debt pressure the business model.
CAVA Group’s earnings arrive amid food-safety headlines and parasite scares, testing how the fast-casual chain navigates reputational headwinds.
Taken together, the preview shows why earnings reactions depend not only on demand, but also on legal exposure, capital intensity, and trust.
What was said on this episode
11 statements · 2 positive · 7 negative · 2 mixed
Hims & Hers beat EPS estimates in six of the last ten quarters.
“The company has beat EPS estimate 6th of the last 10 quarters.”
Listen at 1:17
Hims & Hers subscriber growth is currently slowing.
“However, that growth is kind of slowing down right now.”
Listen at 1:24
Hims & Hers stock has fallen about 9% this quarter.
“The stock is down about 9% this quarter alone.”
Listen at 1:51
The FTC lawsuit alleges Hims & Hers misled customers into recurring subscriptions.
“the lawsuit is alleging that Hims and hers has misled customers into locking themselves into recurring subscriptions.”
Listen at 2:45
Hims & Hers allegedly shared customer information with Meta and Snap.
“the company has shared private information with Meta and Snap despite saying that they were protective of customer privacy.”
Listen at 2:54
CoreWeave earnings will indicate whether AI demand offsets data-center and debt costs.
“Earnings from CoreWeave Ticker CRWV will show whether enormous AI demand can outweigh the heavy cost of data centers and debt.”
Listen at 3:40
CoreWeave’s share price is underperforming.
“the share price is underperforming”
Listen at 4:23
CoreWeave missed EPS estimates in four of the last five quarters.
“The company has missed EPS estimates four times out of the last five quarters.”
Listen at 4:49
Cava earnings should show resilient traffic, profits, and new-store growth.
“the earnings for Kava Group really need to show that customer traffic, restaurant profits and new store growth is remaining strong despite these headwinds.”
Listen at 5:43
Cava stock is up 13% year-to-date but down 11% this month.
“the stock is up around 13% this year, but down about 11% this month”
Listen at 6:09
Cava may be near the center of the Cyclospora-related lettuce issue.
“Kava I think it could represent in many respects close to the epicenter of this issue with Cyclospora”
Listen at 6:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Listen to the full episode and explore every guest, topic, and moment on PodLume.

Judy Lagrou
Hims & Hers Health
Federal Trade Commission
Artificial Intelligence
CoreWeave
CAVA Group, Inc.